OFG
NVO

OmniStar Financial Group’s Novo Nordisk NVO Stock Holding History

OmniStar Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,460
Closed -$647K – 160
2021
Q2 		$647K Buy
+15,460
New +$599K 0.8% 49
2018
Q4 		– Sell
-11,542
Closed -$455K – 138
2018
Q3 		$455K Buy
+11,542
New +$282K 0.35% 94

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OmniStar Financial Group's NVO Position: Q1 2024 in Review

OmniStar Financial Group sold out of Novo Nordisk (NVO) in Q1 2024, closing a stake of 6,255 shares — an estimated $647K sold.

OmniStar Financial Group first reported a position in NVO in Q4 2017 and held it in 24 quarters. The position peaked at $4.11M in Q4 2017. 1,744 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • OmniStar Financial Group reported no remaining Novo Nordisk position as of Q1 2024 after selling out during the quarter.
  • OmniStar Financial Group sold 6,255 Novo Nordisk shares in Q1 2024, an estimated $647K.
  • OmniStar Financial Group first reported a position in Novo Nordisk in Q4 2017 and held it in 24 quarters.
  • OmniStar Financial Group's Novo Nordisk position peaked at $4.11M in Q4 2017.
  • 1,744 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on OmniStar Financial Group's 13F filing for Q1 2024, filed 23 Apr 2024.